What is the success rate of stem cell therapy for Hip Osteoarthritis?
A reliable success rate for hip-OA cell or exosome therapy is not established. Pain, function, imaging structure and avoidance of joint replacement are different endpoints and should not be merged. Disease stage may influence outcome, but current heterogeneous studies cannot predict an individual response. The registered studies and their own prespecified endpoints are listed in the registry table on this page.
What the evidence shows for Hip Osteoarthritis
Human hip-OA studies of cell and related biological products vary by disease severity, product, dose, comparator, imaging method, rehabilitation and endpoint. Pain or function changes do not establish cartilage repair, and uncontrolled imaging changes cannot prove slower progression or avoidance of joint replacement. No pooled response rate is published here because the studies are too heterogeneous for a single figure to be meaningful. The registered studies and their own prespecified endpoints are listed in the registry table on this page.
Am I a candidate? → · Hip Osteoarthritis: full overview → · Hip Osteoarthritis cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.